Tau protein, phospohorylated tau protein, and beta-amyloid 42 levels in patients with neurodegenerative diseases complicated by cognitive deficits
2009
Abstrakt
Background: The differential diagnosis of many nerodegenerative disorders depend primarily on clinical symptoms together with imaging methods. Recently, increased importance has been placed on the use of biomarkers for diagnosing various neurodegenerative disorders.
Objective: To assess the feasibility of tau-protein, phosphorylated tau-protein, beta-amyloid 42 (Abeta42), and 14-3-3 protein as biomarkers for diagnosis several neurodegenerative diseases complicated by cognitive deficits.